NUVALENT INC reports a Return on Equity (ROE) of -38.32%.

What is NUVL's dividend yield?

NUVALENT INC offers a dividend yield of 0.00%.

What is NUVL's Deepscope Quality Score?

Deepscope rates NUVL's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NUVL?

Deepscope's AI Timing Score for NUVL is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NUVL belong to?

NUVALENT INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu NUVL (NASDAQ) | NUVALENT INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-04 | FS: 2026-03-31)

NUVL

NUVALENT INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 87

USD 94.02

3.84 (4.26%) Day Change

Watchlist Portfolio Compare Chart

0.13

D/E

-38.3%

ROE

-33.8%

ROA

0.00%

Div Yield

NUVALENT INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 94.02 Price 3.84 (4.26%) Day Change	NEWS SCORE: 87

NUVL Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) và Thời điểm mua ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	87
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	94.02
PBV / Sector	6.22 / 4.58
Earning Per Share	-5.79

PE / Sector	N/A / 17.10
PEG or PE/Growth / Sector	N/A / 0.52
Average 1M Daily Value	77.44 M
Average 1W Daily Value	154.52 M GREAT

Yếu tố Kỹ thuật

14%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 450.23
NPM Average (%) / Sector	N/A / -1,506.33
NPM Change Average (%) / Sector	N/A / 4,941.30
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-33.81 / 30.58
ROA Average (%) / Sector	-23.84 / -347.17
ROA Change Average (%) / Sector	22.50 / 5,125.52 GREAT
ROE (%) / Sector	-38.32 / -3.58
ROE Average (%) / Sector	-26.13 / 40.65
ROE Change Average (%) / Sector	25.32 / 2,109.80 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.50
Dividend Change Average (%) / Sector	N/A / 5.02

Chi tiết đăng ký

Analyze Date	2026-06-05 09:11:54
Symbol	NUVL
Name	NUVALENT INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	73.56 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	7,304.15 / 8,655.90

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: One Broadway, Cambridge, MA, United States, 02142

Phone: 857 357 7000

Website: https://nuvalent.com

Employees: 234

Sector: Healthcare >> Biotechnology

Description: Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are Zidesamtinib (NVL-520), a novel ROS1-selective inhibitor to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of ROS1 tyrosine kinase inhibitors (TKIs) for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC) which is under the Phase 2 portion of the ARROS-1 Phase 1/2 clinical trial; Neladalkib (NVL-655), a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under the Phase 2 portion of the ALKOVE-1 clinical trial; and NVL-330, a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to treat tumors driven by HER2ex20, brain metastases, and avoiding treatment-limiting adverse events including due to off-target inhibition of wild-type EGFR that is in Phase 1a/1b clinical trial. Nuvalent, Inc. has a strategic partnership with Guardant Health, Inc. to develop companion diagnostics therapies. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.